1. Home
  2. TPCS vs IPSC Comparison

TPCS vs IPSC Comparison

Compare TPCS & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPCS
  • IPSC
  • Stock Information
  • Founded
  • TPCS 1956
  • IPSC 2019
  • Country
  • TPCS United States
  • IPSC United States
  • Employees
  • TPCS N/A
  • IPSC N/A
  • Industry
  • TPCS Metal Fabrications
  • IPSC Medicinal Chemicals and Botanical Products
  • Sector
  • TPCS Industrials
  • IPSC Health Care
  • Exchange
  • TPCS Nasdaq
  • IPSC Nasdaq
  • Market Cap
  • TPCS 44.9M
  • IPSC 49.1M
  • IPO Year
  • TPCS N/A
  • IPSC 2021
  • Fundamental
  • Price
  • TPCS $4.70
  • IPSC $0.54
  • Analyst Decision
  • TPCS
  • IPSC Strong Buy
  • Analyst Count
  • TPCS 0
  • IPSC 5
  • Target Price
  • TPCS N/A
  • IPSC $3.33
  • AVG Volume (30 Days)
  • TPCS 32.0K
  • IPSC 1.3M
  • Earning Date
  • TPCS 08-21-2025
  • IPSC 11-07-2025
  • Dividend Yield
  • TPCS N/A
  • IPSC N/A
  • EPS Growth
  • TPCS N/A
  • IPSC N/A
  • EPS
  • TPCS N/A
  • IPSC N/A
  • Revenue
  • TPCS $33,424,000.00
  • IPSC $114,128,000.00
  • Revenue This Year
  • TPCS N/A
  • IPSC $1,589.94
  • Revenue Next Year
  • TPCS N/A
  • IPSC N/A
  • P/E Ratio
  • TPCS N/A
  • IPSC N/A
  • Revenue Growth
  • TPCS 3.78
  • IPSC 5491.77
  • 52 Week Low
  • TPCS $2.05
  • IPSC $0.34
  • 52 Week High
  • TPCS $6.25
  • IPSC $1.83
  • Technical
  • Relative Strength Index (RSI)
  • TPCS 43.52
  • IPSC 46.27
  • Support Level
  • TPCS $4.13
  • IPSC $0.51
  • Resistance Level
  • TPCS $4.96
  • IPSC $0.58
  • Average True Range (ATR)
  • TPCS 0.35
  • IPSC 0.04
  • MACD
  • TPCS -0.01
  • IPSC -0.01
  • Stochastic Oscillator
  • TPCS 36.82
  • IPSC 26.34

About TPCS TechPrecision Corporation Common stock

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

Share on Social Networks: